THE EFFECT OF DEXMEDETOMIDINE ON RADIOGRAPHIC CARDIAC SILHOUETTE SIZE IN HEALTHY CATS

Area of Science:

• Veterinary Radiology
• Cardiology
• Pharmacology

Background:

• Dexmedetomidine is an alpha2-adrenergic agonist used for chemical restraint in companion animals.
• Echocardiographic changes from alpha2-adrenergic agonists are documented, but radiographic changes in cats were not previously reported.
• Understanding drug effects on imaging is vital for accurate veterinary diagnostics.

Purpose of the Study:

• To investigate the effects of dexmedetomidine on the cardiac silhouette's radiographic appearance in healthy adult cats.
• To provide data for accurate interpretation of thoracic radiographs in dexmedetomidine-sedated cats.

Main Methods:

• An observational, prospective, experimental study involving 14 healthy adult cats.
• Dexmedetomidine (40 mcg/kg IM) was administered, with radiographs taken pre-sedation, during sedation, and post-sedation.
• Radiographs (right lateral, left lateral, ventrodorsal, dorsoventral) were evaluated by two blinded observers using vertebral heart score and thoracic width measurements.

Main Results:

• A significant increase in median vertebral heart score on right lateral views was observed during sedation compared to pre-sedation (P = 0.001).
• Median percentage width of the thorax significantly increased on ventrodorsal (P = 0.001) and dorsoventral (P = 0.006) views during sedation.
• Dexmedetomidine administration resulted in a small but statistically significant enlargement of the cardiac silhouette on radiographs.

Conclusions:

• Dexmedetomidine administration is associated with a measurable increase in cardiac silhouette size on thoracic radiographs in healthy cats.
• Veterinarians should consider this effect when interpreting radiographs of dexmedetomidine-sedated cats to avoid misdiagnosis.
• This study highlights the importance of accounting for pharmacologic agents during radiographic interpretation in veterinary medicine.